Clincosm LogoSign in Get a demo

lymphoma

Showing NaN - NaN of 246
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma, Lymphoma, Large B-Cell, Diffuse, Pleiotropic Pathway Modifier Trial in Worldwide (CC-122)

Active, not recruiting
  • Multiple Myeloma
  • +5 more
  • Duarte, California
  • +38 more
Aug 18, 2022

Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1429 more
Aug 17, 2022

Lymphoma, Nonneoplastic Condition Trial in United States (bleomycin sulfate, filgrastim, ABVD regimen)

Completed
Has Results
  • Lymphoma
  • Nonneoplastic Condition
  • bleomycin sulfate
  • +11 more
  • Tucson, Arizona
  • +422 more
Aug 16, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +7 more
  • Duarte, California
  • +26 more
Aug 11, 2022

Locally Advanced Solid Tumors, Metastatic Solid Tumors, Lymphoma Trial in Worldwide (Oral repotrectinib (TPX-0005))

Recruiting
  • Locally Advanced Solid Tumors
  • +3 more
  • Oral repotrectinib (TPX-0005)
  • Los Angeles, California
  • +27 more
Aug 9, 2022

Collecting and Storing Tissue From Young Patients With Cancer

Recruiting
  • Acute Lymphoblastic Leukemia
  • +13 more
  • Cytology Specimen Collection Procedure
  • Laboratory Biomarker Analysis
  • Birmingham, Alabama
  • +68 more
Aug 4, 2022

Leukemia, Myelodysplastic Syndrome, Lymphoma Trial in New York (CliniMACS Fractionation system (Arm A), CliniMACS Fractionation

Completed
Has Results
  • Leukemia
  • +2 more
  • CliniMACS Fractionation system (Arm A)
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 12, 2022

Lymphoma Trial in Worldwide (CC-220, Rituximab, Obinutuzumab)

Recruiting
  • Lymphoma
  • Phoenix, Arizona
  • +36 more
Jul 28, 2022

Hematopoietic and Lymphoid System Tumor, Leukemia, Lymphoma Trial in Canada, United States (procedure, biological, other)

Active, not recruiting
  • Hematopoietic and Lymphoid System Neoplasm
  • +3 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +3 more
  • Birmingham, Alabama
  • +42 more
Jul 20, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Lymphoma Trial in United States (biological, drug, procedure)

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +3 more
  • BPX-501 dose 1
  • +5 more
  • Atlanta, Georgia
  • +7 more
Jul 10, 2022

Breast Cancer, Head Neck Cancer, Squamous Cell Carcinoma Trial in Canada, United States (INT230-6, anti-PD-1 antibody,

Active, not recruiting
  • Breast Cancer
  • +10 more
  • Los Angeles, California
  • +7 more
Jun 21, 2022

Solid Tumors, Lymphoma Trial in Worldwide (Ulevostinag, Pembrolizumab)

Completed
  • Solid Tumors
  • Lymphoma
  • Birmingham, Alabama
  • +18 more
Jun 10, 2022

Lymphoma, Multiple Myeloma Trial in Worldwide (Lenalidomide, Dexamethasone, Dexamethasone (Oral))

Completed
Has Results
  • Lymphoma
  • Multiple Myeloma
  • Muscle Shoals, Alabama
  • +215 more
May 5, 2022

Lymphoma, Multiple Myeloma, Non-Hodgkin Lymphoma Trial in New York (Isatuximab, Standard Procedures)

Recruiting
  • Lymphoma
  • +3 more
  • New York, New York
    Columbia University
Apr 27, 2022

Solid Tumor, CNS Tumor, Lymphoma Trial in Canada, United States (Neratinib)

Recruiting
  • Solid Tumor
  • +3 more
  • Phoenix, Arizona
  • +8 more
Mar 21, 2022

GI Cancer, Lymphoma, GU Cancer Trial in New York (Self-Efficacy Assessment, UCLA Geriatrics Attitudes Scale, Course Evaluations)

Active, not recruiting
  • GI Cancer
  • +3 more
  • Self-Efficacy Assessment
  • +5 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Mar 16, 2022

Leukemia, Lymphoma, Lymphoma, B-Cell Trial in New York (CAR T-Cell Infusion)

Withdrawn
  • Leukemia
  • +2 more
  • CAR T-Cell Infusion
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Mar 4, 2022

Lymphoma Trial in United States (rituximab, Bendamustin, bortezomib)

Active, not recruiting
Has Results
  • Lymphoma
  • rituximab
  • +3 more
  • Greenbrae, California
  • +226 more
Mar 7, 2022

Longitudinal Sexual and Reproductive Health Study of Breast

Recruiting
  • Breast Cancer
  • +2 more
  • surveys
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Mar 1, 2022

Solid Tumor, Lymphoma Trial in Worldwide (CX-072, ipilimumab, vemurafenib)

Completed
  • Solid Tumor
  • Lymphoma
  • Los Angeles, California
  • +30 more
Feb 7, 2022

Mantle Cell Lymphoma, Lymphoma Trial in United States (BR-I (bendamustine, rituximab, ibrutinib), VEN (Venetoclax))

Active, not recruiting
  • Mantle Cell Lymphoma
  • Lymphoma
  • BR-I (bendamustine, rituximab, ibrutinib)
  • VEN (Venetoclax)
  • Basking Ridge, New Jersey
  • +6 more
Feb 3, 2022

Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell Trial in Worldwide (Durvalumab, Lenalidomide, Rituximab)

Active, not recruiting
Has Results
  • Lymphoma
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Gilbert, Arizona
  • +53 more
Jan 25, 2022

Lymphoma Trial in Worldwide (Nivolumab)

Completed
Has Results
  • Lymphoma
  • Phoenix, Arizona
  • +44 more
Dec 13, 2021

Lymphoma Trial in Worldwide (Nivolumab)

Completed
Has Results
  • Lymphoma
  • Birmingham, Alabama
  • +49 more
Nov 24, 2021

Lymphoma Trial in United States (ABVD, BEACOPP, radiation therapy)

Completed
Has Results
  • Lymphoma
  • Saint Helena, California
  • +54 more
Nov 5, 2021